The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Discover whether stocks or bonds are better for achieving financial freedom. Start making smarter investment decisions today.
26,067 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Federal Reserve Governor Christopher Waller signaled that he does not support additional rate hikes for now and expec...
Across 460+ real-life millionaire interviews, readers gain practical, proven money strategies. This article shows how...
NVIDIA’s GTC 2026 unveiled a broader AI-infrastructure push, signaling that nvidia’s developments were bigger than in...
Bitmine reports a fresh ETH purchase of 65,341 coins, pushing its total ETH stash to 4.661 million and fueling optimi...
As markets swing in 2026, savers confront whether their 401(k) targets match reality. This report breaks down age-by-...
Piper Sandler trimmed its Upstart price target to $46 after a softer Q1 EBITDA print, but kept an Overweight rating a...
Bitcoin sits at a regulatory crossroads as Consensus 2026 brings renewed debate over the Clarity Act. Hayes argues th...
A rapid Trump-backed rally has pushed stocks to fresh highs, yet selective bargains remain. The market shows pockets ...
A new Grok AI forecast linked to Elon Musk projects XRP reaching up to $7 by late 2026. The forecast comes as ETFs, r...
Meta's internal AI model is circulating a long-range Bitcoin forecast for end-2026, highlighting supply constraints, ...
As 2026 unfolds, Resideo's earnings trajectory blends hardware sales with growing recurring revenue. This guide break...